Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells

Journal of Immunology

Volumn 188, Issue 1, 2012, Pages 404-416

  Zompi, Simona ^a   Santich, Brian H ^a   Beatty, P Robert ^a,b   Harris, Eva ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California Berkeley   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; CD79B ANTIGEN; GAMMA INTERFERON RECEPTOR; IMMUNOGLOBULIN D; INTERLEUKIN 10; MONOCLONAL ANTIBODY; SYNDECAN 1;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CELL SPECIFICITY; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMORAL IMMUNITY; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MORTALITY; MOUSE; NONHUMAN; PLASMA CELL; PRIORITY JOURNAL; SECONDARY INFECTION; SEROTYPE; SPLEEN CELL; SURVIVAL; T CELL DEPLETION; T LYMPHOCYTE; VIRUS NEUTRALIZATION;

ANIMALS; ANTIGENS, VIRAL; CELL LINE; CROSS REACTIONS; DENGUE HEMORRHAGIC FEVER; DENGUE VIRUS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOLOGIC MEMORY; INTERFERONS; MICE; MICE, MUTANT STRAINS; PLASMA CELLS; T-LYMPHOCYTES;

EID: 84855410183     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102124     Document Type: Article

References (60)

1. Gubler, D. J. 2002. Epidemic dengue/dengue hemorrhagic fever as a public health, social and economic problem in the 21st century. Trends Microbiol. 10: 100-103. (Pubitemid 34119347)
2. Guzmán, M. G., G. P. Kouri, J. Bravo, M. Soler, S. Vazquez, and L. Morier. 1990. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am. J. Trop. Med. Hyg. 42: 179-184. (Pubitemid 20093452)
3. Sabin, A. B. 1952. Research on dengue during World War II. Am. J. Trop. Med. Hyg. 1: 30-50.
4. Sangkawibha, N., S. Rojanasuphot, S. Ahandrik, S. Viriyapongse, S. Jatanasen, V. Salitul, B. Phanthumachinda, and S. B. Halstead. 1984. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am. J. Epidemiol. 120: 653-669. (Pubitemid 15210730)
5. Thein, S., M. M. Aung, T. N. Shwe, M. Aye, A. Zaw, K. Aye, K. M. Aye, and J. Aaskov. 1997. Risk factors in dengue shock syndrome. Am. J. Trop. Med. Hyg. 56: 566-572. (Pubitemid 27230081)
6. Rothman, A. L. 2010. Cellular immunology of sequential dengue virus infection and its role in disease pathogenesis. Curr. Top. Microbiol. Immunol. 338: 83-98.
7. Balsitis, S. J., K. L. Williams, R. Lachica, D. Flores, J. L. Kyle, E. Mehlhop, S. Johnson, M. S. Diamond, P. R. Beatty, and E. Harris. 2010. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog. 6: e1000790.
8. Guzmán, M. G., G. Kouri, L. Valdes, J. Bravo, M. Alvarez, S. Vazques, I. Delgado, and S. B. Halstead. 2000. Epidemiologic studies on dengue in Santiago de Cuba, 1997. Am. J. Epidemiol. 152: 793-799, discussion 804.
9. Kliks, S. C., S. Nimmanitya, A. Nisalak, and D. S. Burke. 1988. Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants. Am. J. Trop. Med. Hyg. 38: 411-419. (Pubitemid 18086128)
10. Mongkolsapaya, J., W. Dejnirattisai, X. N. Xu, S. Vasanawathana, N. Tangthawornchaikul, A. Chairunsri, S. Sawasdivorn, T. Duangchinda, T. Dong, S. Rowland-Jones, et al. 2003. Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever. Nat. Med. 9: 921-927. (Pubitemid 36889936)
11. Imrie, A., J. Meeks, A. Gurary, M. Sukhbataar, P. Kitsutani, P. Effler, and Z. Zhao. 2007. Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes. J. Virol. 81: 10081-10091. (Pubitemid 350067712)
12. Mangada,M.M., and A. L. Rothman. 2005. Altered cytokine responses of dengue-specific CD4+ T cells to heterologous serotypes. J. Immunol. 175: 2676-2683. (Pubitemid 41113883)
13. Beaumier, C. M., A. Mathew, H. S. Bashyam, and A. L. Rothman. 2008. Cross-reactive memory CD8(+) T cells alter the immune response to heterologous secondary dengue virus infections in mice in a sequence-specific manner. J. Infect. Dis. 197: 608-617. (Pubitemid 351321540)
14. Kliks, S. C., A. Nisalak,W. E. Brandt, L.Wahl, and D. S. Burke. 1989. Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am. J. Trop. Med. Hyg. 40: 444-451. (Pubitemid 19117544)
15. Kochel, T. J., D. M. Watts, S. B. Halstead, C. G. Hayes, A. Espinoza, V. Felices, R. Caceda, C. T. Bautista, Y. Montoya, S. Douglas, and K. L. Russell. 2002. Effect of dengue-1 antibodies on American dengue-2 viral infection and dengue haemorrhagic fever. Lancet 360: 310-312. (Pubitemid 34874726)
16. Kyle, J. L., S. J. Balsitis, L. Zhang, P. R. Beatty, and E. Harris. 2008. Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model. Virology 380: 296-303.
17. McHeyzer-Williams, L. J., and M. G. McHeyzer-Williams. 2005. Antigenspecific memory B cell development. Annu. Rev. Immunol. 23: 487-513.
18. Leyendeckers, H., M. Odendahl, A. Löhndorf, J. Irsch, M. Spangfort, S. Miltenyi, N. Hunzelmann, M. Assenmacher, A. Radbruch, and J. Schmitz. 1999. Correlation analysis between frequencies of circulating antigen-specific IgG-bearing memory B cells and serum titers of antigen-specific IgG. Eur. J. Immunol. 29: 1406-1417. (Pubitemid 29164188)
19. Amanna, I. J., and M. K. Slifka. 2010. Mechanisms that determine plasma cell lifespan and the duration of humoral immunity. Immunol. Rev. 236: 125-138.
20. Ahuja, A., S. M. Anderson, A. Khalil, and M. J. Shlomchik. 2008. Maintenance of the plasma cell pool is independent of memory B cells. Proc. Natl. Acad. Sci. USA 105: 4802-4807. (Pubitemid 351753827)
21. Williams, K. L., S. Zompi, P. R. Beatty, and E. Harris. 2009. A mouse model for studying dengue virus pathogenesis and immune response. Ann. N. Y. Acad. Sci. 1171(Suppl. 1): E12-E23.
22. Kyle, J. L., P. R. Beatty, and E. Harris. 2007. Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J. Infect. Dis. 195: 1808-1817. (Pubitemid 46870254)
23. Shresta, S., K. L. Sharar, D. M. Prigozhin, P. R. Beatty, and E. Harris. 2006. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J. Virol. 80: 10208-10217. (Pubitemid 44522614)
24. Balsitis, S. J., J. Coloma, G. Castro, A. Alava, D. Flores, J. H. McKerrow, P. R. Beatty, and E. Harris. 2009. Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am. J. Trop. Med. Hyg. 80: 416-424.
25. Prestwood, T. R., D. M. Prigozhin, K. L. Sharar, R. M. Zellweger, and S. Shresta. 2008. A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads. J. Virol. 82: 8411-8421.
26. Loveless, S. E., G. S. Ladics, C. Smith, M. P. Holsapple, M. R. Woolhiser, K. L. White, Jr., D. L. Musgrove, R. J. Smialowicz, and W. Williams. 2007. Interlaboratory study of the primary antibody response to sheep red blood cells in outbred rodents following exposure to cyclophosphamide or dexamethasone. J. Immunotoxicol. 4: 233-238. (Pubitemid 47360096)
27. Miyauchi, A., C. Hiramine, S. Tanaka, and K. Hojo. 1990. Differential effects of a single dose of cyclophosphamide on T cell subsets of the thymus and spleen in mice: flow cytofluorometry analysis. Tohoku J. Exp. Med. 162: 147-167.
28. Yauch, L. E., R. M. Zellweger, M. F. Kotturi, A. Qutubuddin, J. Sidney, B. Peters, T. R. Prestwood, A. Sette, and S. Shresta. 2009. A protective role for dengue virus-specific CD8+ T cells. J. Immunol. 182: 4865-4873.
29. Yauch, L. E., T. R. Prestwood, M. M. May, M. M. Morar, R. M. Zellweger, B. Peters, A. Sette, and S. Shresta. 2010. CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination. J. Immunol. 185: 5405-5416.
30. Holden, K. L., D. A. Stein, T. C. Pierson, A. A. Ahmed, K. Clyde, P. L. Iversen, and E. Harris. 2006. Inhibition of dengue virus translation and RNA synthesis by a morpholino oligomer targeted to the top of the terminal 39 stem-loop structure. Virology 344: 439-452. (Pubitemid 43049631)
31. Shresta, S., J. L. Kyle, P. Robert Beatty, and E. Harris. 2004. Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology 319: 262-273. (Pubitemid 38251267)
32. Kraus, A. A., W. Messer, L. B. Haymore, and A. M. de Silva. 2007. Comparison of plaque- and flow cytometry-based methods for measuring dengue virus neutralization. J. Clin. Microbiol. 45: 3777-3780. (Pubitemid 350156883)
33. Lindsey, N. P., B. A. Schroeder, E. R. Miller, M. M. Braun, A. F. Hinckley, N. Marano, B. A. Slade, E. D. Barnett, G. W. Brunette, K. Horan, et al. 2008. Adverse event reports following yellow fever vaccination. Vaccine 26: 6077-6082.
34. Benner, R., A. van Oudenaren, and G. Koch. 1981. Induction of Antibody Formation in Mouse Bone Marrow. Academic Press, New York.
35. Crotty, S., R. D. Aubert, J. Glidewell, and R. Ahmed. 2004. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J. Immunol. Methods 286: 111-122. (Pubitemid 38490401)
36. Pierson, T. C., M. D. Sánchez, B. A. Puffer, A. A. Ahmed, B. J. Geiss, L. E. Valentine, L. A. Altamura, M. S. Diamond, and R. W. Doms. 2006. A rapid and quantitative assay for measuring antibody-mediated neutralization of West Nile virus infection. Virology 346: 53-65. (Pubitemid 43254699)
37. Delgado, M. F., S. Coviello, A. C. Monsalvo, G. A. Melendi, J. Z. Hernandez, J. P. Batalle, L. Diaz, A. Trento, H. Y. Chang, W. Mitzner, et al. 2009. Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease. Nat. Med. 15: 34-41.
38. Polack, F. P., S. J. Hoffman, G. Crujeiras, and D. E. Griffin. 2003. A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. Nat. Med. 9: 1209-1213. (Pubitemid 37173707)
39. Slifka, M. K., and R. Ahmed. 1998. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr. Opin. Immunol. 10: 252-258. (Pubitemid 28286950)
40. Slifka, M. K., R. Antia, J. K. Whitmire, and R. Ahmed. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8: 363-372. (Pubitemid 28188896)
41. Cenci, S., A. Mezghrani, P. Cascio, G. Bianchi, F. Cerruti, A. Fra, H. Lelouard, S. Masciarelli, L. Mattioli, L. Oliva, et al. 2006. Progressively impaired proteasomal capacity during terminal plasma cell differentiation. EMBO J. 25: 1104-1113. (Pubitemid 43372123)
42. Lanzavecchia, A., N. Bernasconi, E. Traggiai, C. R. Ruprecht, D. Corti, and F. Sallusto. 2006. Understanding and making use of human memory B cells. Immunol. Rev. 211: 303-309. (Pubitemid 43882981)
43. Sercan, O., D. Stoycheva, G. J. Hämmerling, B. Arnold, and T. Schüler. 2010. IFN-gamma receptor signaling regulates memory CD8+ T cell differentiation. J. Immunol. 184: 2855-2862.
44. Gromowski, G. D., and A. D. Barrett. 2007. Characterization of an antigenic site that contains a dominant, type-specific neutralization determinant on the envelope protein domain III (ED3) of dengue 2 virus. Virology 366: 349-360. (Pubitemid 47398915)
45. Zellweger, R. M., T. R. Prestwood, and S. Shresta. 2010. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe 7: 128-139.
46. Halstead, S. B. 1982. Immune enhancement of viral infection. Prog. Allergy 31: 301-364.
47. Halstead, S. B., and E. J. O'Rourke. 1977. Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. J. Exp. Med. 146: 201-217. (Pubitemid 8139503)
48. Halstead, S. B., and E. J. O'Rourke. 1977. Antibody-enhanced dengue virus infection in primate leukocytes. Nature 265: 739-741. (Pubitemid 8039460)
49. Parren, P. W., and D. R. Burton. 2001. The antiviral activity of antibodies in vitro and in vivo. Adv. Immunol. 77: 195-262. (Pubitemid 33703707)
50. Pierson, T. C., D. H. Fremont, R. J. Kuhn, and M. S. Diamond. 2008. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host Microbe 4: 229-238.
51. Burton, D. R. 2002. Antibodies, viruses and vaccines. Nat. Rev. Immunol. 2: 706-713. (Pubitemid 37328728)
52. Dowd, K. A., and T. C. Pierson. 2011. Antibody-mediated neutralization of flaviviruses: a reductionist view. Virology 411: 306-315.
53. de Souza, V. A., S. Fernandes, E. S. Araújo, A. F. Tateno, O. M. Oliveira, R. R. Oliveira, and C. S. Pannuti. 2004. Use of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections. J. Clin. Microbiol. 42: 1782-1784. (Pubitemid 38500840)
54. Matheus, S., X. Deparis, B. Labeau, J. Lelarge, J. Morvan, and P. Dussart. 2005. Use of four dengue virus antigens for determination of dengue immune status by enzyme-linked immunosorbent assay of immunoglobulin G avidity. J. Clin. Microbiol. 43: 5784-5786. (Pubitemid 41612364)
55. Matheus, S., X. Deparis, B. Labeau, J. Lelarge, J. Morvan, and P. Dussart. 2005. Discrimination between primary and secondary dengue virus infection by an immunoglobulin G avidity test using a single acute-phase serum sample. J. Clin. Microbiol. 43: 2793-2797. (Pubitemid 40827955)
56. Midgley, C. M., M. Bajwa-Joseph, S. Vasanawathana, W. Limpitikul, B. Wills, A. Flanagan, E. Waiyaiya, H. B. Tran, A. E. Cowper, P. Chotiyarnwon, et al. 2011. An in-depth analysis of original antigenic sin in dengue virus infection. J. Virol. 85: 410-421.
57. Smith, K. G., A. Light, G. J. Nossal, and D. M. Tarlinton. 1997. The extent of affinity maturation differs between the memory and antibody-forming cell compartments in the primary immune response. EMBO J. 16: 2996-3006. (Pubitemid 27234939)
58. Hebeis, B. J., K. Klenovsek, P. Rohwer, U. Ritter, A. Schneider, M. Mach, and T. H. Winkler. 2004. Activation of virus-specific memory B cells in the absence of T cell help. J. Exp. Med. 199: 593-602. (Pubitemid 38233842)
59. Cambridge, G., M. J. Leandro, J. C. Edwards, M. R. Ehrenstein, M. Salden, M. Bodman-Smith, and A. D. Webster. 2003. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Arthritis Rheum. 48: 2146-2154. (Pubitemid 36959194)
60. Sabin, A. B. 1950. The dengue group of viruses and its family relationships. Bacteriol. Rev. 14: 225-232.